SELLAS Life Sciences Group, Inc. — Director's Dealing 2014

Feb 4, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Galena Biopharma, Inc. (GALE)
CIK: 0001390478
Period of Report: 2014-01-30

Reporting Person: Chin Richard (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-01-30	Common Stock	M	50000	$0.72	Acquired	50000	Direct
2014-01-30	Common Stock	M	25000	$0.85	Acquired	75000	Direct
2014-01-30	Common Stock	S	50000	$5.57	Disposed	25000	Direct
2014-01-30	Common Stock	S	25000	$5.6102	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-01-30	Stock Option (right to buy)	$0.72	M	50000	Disposed	2022-01-12	Common Stock (50000)	Direct
2014-01-30	Stock Option (right to buy)	$0.85	M	25000	Disposed	2021-09-27	Common Stock (25000)	Direct

Footnotes

F1: The option vested in equal quarterly installments of 12,500 shares on each of April 12, 2012, July 12, 2012, October 12, 2012 and January 12, 2013